Pharmaceutical marketers already follow a stack of rules when they advertise, which includes listing dangerous possible side effects to a sometimes unnerving length. Now a newly proposed requirement to disclose list prices for drugs on-screen during television commercials could add yet another headache for one of Madison Avenue’s most important categories.